RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Net debt

Edwards Lifesciences CorpEW

Market cap
$49.7B
P/E ratio
SummaryFinancials
Period EndNet debt (Million USD)YoY (%)
Dec 31, 2024-3,392+222.57%
Dec 31, 2023-1,051+68.89%
Dec 31, 2022-623-28.90%
Dec 31, 2021-876+6.20%
Dec 31, 2020-825-10.61%
Dec 31, 2019-922+154.34%
Dec 31, 2018-363+20.46%
Dec 31, 2017-301-32.91%
Dec 31, 2016-449-28.51%
Dec 31, 2015-628-25.32%
Dec 31, 2014-841-586.80%
Dec 31, 2013173

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)